Glasgow Royal Infirmary
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1794-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
7
Active:0
Completed:4
Trial Phases
3 Phases
Phase 2:1
Phase 4:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (50.0%)Phase 2
1 (25.0%)Phase 4
1 (25.0%)Advanced Pelvic Surgical Oncology Database - Prospective Observational Study
Recruiting
- Conditions
- Colon CancerRectal CancerGynecologic CancerPelvic Cancer
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Glasgow Royal Infirmary
- Target Recruit Count
- 300
- Registration Number
- NCT05696002
- Locations
- 🇬🇧
Academic Department of Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom
Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection
- Conditions
- COVID-19
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Glasgow Royal Infirmary
- Target Recruit Count
- 250
- Registration Number
- NCT04484545
- Locations
- 🇬🇧
Glasgow Royal Infirmary, Glasgow, United Kingdom
Re-engaging Patients With Hepatitis C Into Care
Not Applicable
- Conditions
- Hepatitis C, Chronic
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Glasgow Royal Infirmary
- Target Recruit Count
- 1000
- Registration Number
- NCT04029246
- Locations
- 🇬🇧
Glasgow Royal Infirmary, Glasgow, United Kingdom
Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)
Completed
- Conditions
- Thiamine DeficiencyMagnesium DeficiencyIron-deficiencyInflammation
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Glasgow Royal Infirmary
- Target Recruit Count
- 47
- Registration Number
- NCT03554668
- Locations
- 🇬🇧
Glasgow Royal Infirmary, Glasgow, United Kingdom
Alcohol: Thiamine and or Magnesium 1
Phase 2
Completed
- Conditions
- Vitamin B1 DeficiencyAlcohol WithdrawalLactic AcidosisWernicke EncephalopathyMagnesium Deficiency
- Interventions
- Drug: Pabrinex
- First Posted Date
- 2018-03-15
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- Glasgow Royal Infirmary
- Target Recruit Count
- 127
- Registration Number
- NCT03466528
- Locations
- 🇬🇧
Glasgow Royal Infirmary, Glasgow, United Kingdom
- Prev
- 1
- 2
- Next
News
No news found